Multiple Myeloma Current Events | Multiple Myeloma News | 7
|
| Page
7 of
13 |
259 Results |
|
|
|
Sort By:
Page Views | Date |
Potential new target for multiple sclerosis therapy
Researchers demonstrate both genetic and pharmaceutical evidence for the role of a protein called collagenase-2 in the development of multiple sclerosis (MS), providing a potential new way to combat this debilitating disease. view more (2008-03-31)
STDs disrupt genetic bottleneck that usually constrains HIV infection
Scientists have shown that HIV faces a genetic "bottleneck" when the virus is transmitted heterosexually from one person to another, by way of the genital mucosa. view more (2009-01-23)
Factors from common human bacteria may trigger multiple sclerosis
Current research suggests that a common oral bacterium may exacerbate autoimmune disease. The related report by Nichols et al, "Unique Lipids from a Common Human Bacterium Represent a New Class of TLR2 Ligands Capable of Enhancing Autoimmunity," appears in the December 2009 issue of The American Journal of Pathology. view more (2009-11-24)
Oral osteoporosis meds appear to reduce the risk of jaw degradation
Athanasios Zavras began receiving messages from distraught patients in 2005 after case reports linked oral osteoporosis meds to bone death in the jaw. view more (2008-01-03)
WHAT FUTURE FOR CANNABIS?
The potential therapeutic effects of cannabis are outlined in a review in the May issue of THE LANCET NEUROLOGY. The review is published in anticipation of results from randomised trials expected later this year investigating possible benefits of the drug for people with multiple sclerosis. The first cannabis-based medicines are currently being... view more... (2003-04-16)
Human behavior changes the number of strains of infectious diseases
Simple models predict that only one strain of an infectious disease can exist at one time, but observation suggests otherwise. view more (2006-07-27)
Tiny crystals promise big benefits for solar technologies
Los Alamos National Laboratory scientists have discovered that a phenomenon called carrier multiplication, in which semiconductor nanocrystals respond to photons by producing multiple electrons, is applicable to a broader array of materials that previously thought. view more (2006-01-05)
Monitoring immune responses in disease
A recent study published in Clinical Immunology, the official journal of the Clinical Immunology Society (CIS), describes a new method enabling the detection of multiple parameters of single human cells. view more (2008-09-04)
Identifying the metabolism of a healthy embryo could improve infertility treatment
Embryos that are most likely to result in a pregnancy are crucial to the success of in vitro fertilization (IVF) but are difficult to identify. Researchers at Yale School of Medicine, led by Emre Seli, M.D., are developing a fast, non-invasive test to help assess embryo viability for IVF. view more (2009-10-21)
Multiple sclerosis research charges ahead with new mouse model of disease
A new study highlights the role of a charge-switching enzyme in nervous system deficits characteristic of multiple sclerosis and other related neurological illness. view more (2008-11-06)
'Erectile dysfunction' drugs heighten natural anti-cancer activity
Sildenafil and other "impotence drugs" that boost the production of a gassy chemical messenger to dilate blood vessels and produce an erection now also show promise in unmasking cancer cells so that the immune system can recognize and attack them, say scientists at the Johns Hopkins Kimmel Cancer Center. view more (2006-12-08)
Alcohol cravings and anxiety do not increase with repeat detoxification
People with alcohol problems have no greater anxiety or cravings after the second, third or fourth detoxification than the first, according to a new study by experimental psychologists at the University of Sussex. Previous studies have shown that the risk of seizures can increase with subsequent detoxifications due to the effects of withdrawal... view more... (2002-06-14)
Patients taking Tysabri report improvement in physical and psychological well-being over time
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking TYSABRI® (natalizumab) experienced an improvement in both their physical function and psychological well-being. view more (2009-09-11)
Diabetes drug shows promise against multiple sclerosis
A drug currently FDA-approved for use in diabetes shows some protective effects in the brains of patients with relapsing remitting multiple sclerosis. view more (2009-05-27)
First new multiple sclerosis gene found in 30 years
A newly identified gene may hold the promise of guiding future research into therapies for multiple sclerosis in what its discoverers say is the first major genetic advance in 30 years for understanding this nervous system disease. view more (2007-07-30)
Unmet Need Common Among Patients with Advanced Illness
There is often a lack of adequate communication between health care providers and those facing terminal conditions, according to a series of articles in the latest issue of The Journal of Gerontology: Medical Sciences (Vol. 63, No. 3). view more (2008-10-07)
Doctors perform more IVF treatments, but multiple births decline
Lausanne, Switzerland: The latest figures on in vitro fertilization in Europe reveal the welcome news that while the number of IVF treatment cycles has increased, the number of multiple births is decreasing. Dr Karl Nygren and Dr Anders Nyboe Andersen told the European Society of Human Reproduction and Embryology annual meeting in Lausanne today... view more... (2001-07-02)
Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone
A group of Israeli scientists from the Technion - Israel Institute of Technology, the Weizmann Institute of Science and Teva Pharmaceutical Industries have recently identified genes responsible for the positive response of many multiple sclerosis patients to the drug Copaxone. view more (2007-10-11)
Why do high school seniors drink?
Most high school seniors drink because they want to experiment with alcohol, some drink for the thrill of it, and others because it helps them relax. view more (2007-12-04)
May: Multiple Sclerosis Awareness Month -- latest research is good news
May is Multiple Sclerosis Month and there is no better way of raising awareness for this unpredictable and often debilitating disease then by highlighting the latest research that might offer hope for the 55 to 75, 000 sufferers across Canada. view more (2007-05-03)
|
|
| Page
7 of
13 |
259 Results |
|
|
|
Sort By:
Page Views | Date |
|
